Vir RSS za ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days

Vprašanja

Kateri je URL vira RSS za ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days?

Naslov vira je https://clinicaltrials.gov/api/rss?cond=Alzheimer+Disease&intr=Lecanemab+OR+donanemab+OR+Remternetug+OR+Trontinemab+OR+Crenezumab+OR+Valitramiprostate&dateField=LastUpdatePostDate. Prilepite ga v kateri koli bralnik RSS ali kliknite Spremljaj zdaj, da ga boste brali v aplikaciji Feeder.

Kako pogosto objavlja ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days?

ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days objavlja približno 4-krat na teden. Zadnja objava je bila objavljena pred 1 dan.

Ali vir RSS ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days deluje?

Da. Feeder ga je preveril pred 4 minute in vir se je normalno odzval.

Kako lahko spremljam ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days v aplikaciji Feeder?

Kliknite Spremljaj zdaj in se registrirajte, če še nimate računa. Brezplačni paket Feeder vključuje do 200 virov v spletu ter napravah iPhone in Android. Kreditna kartica ni potrebna.